Benjamin Ory
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 2%
- Bone health and treatments
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
-
- RNA modifications and cancer 8
- Ubiquitin and proteasome pathways 6
- Protein Degradation and Inhibitors 6
- Bone Metabolism and Diseases 4
- Oncology 22
- Bone health and treatments 9
- Cancer-related Molecular Pathways 9
- Co-authors
- Dominique Heymann (32 shared papers)Françoise Rédiní (23 shared papers)François Lamoureux (30 shared papers)Marc Baud’huin (22 shared papers)Marie‐Françoise Heymann (5 shared papers)Leif W. Ellisen (7 shared papers)Marta Tellez Gabriel (4 shared papers)Lidia Rodriguez Calleja (8 shared papers)
- Journals
- Cancers (5 papers)Oncotarget (5 papers)Cancer Research (4 papers)Cells (4 papers)Journal of Clinical Investigation (3 papers)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Benjamin Ory
58 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 109
- Cancer Research 613
- Oncology 952
- Molecular Biology 1.3k
- Pulmonary and Respiratory Medicine 489
- Rheumatology 152
Countries citing papers authored by Benjamin Ory
This map shows the geographic impact of Benjamin Ory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Ory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Ory more than expected).
Fields of papers citing papers by Benjamin Ory
This network shows the impact of papers produced by Benjamin Ory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Ory. The network helps show where Benjamin Ory may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Ory, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 191 | |
| 2 | 2016 | 146 | |
| 3 | 2005 | 130 | |
| 4 | 2014 | 111 | |
| 5 | 2005 | 110 | |
| 6 | 2004 | 109 | |
| 7 | 2018 | 103 | |
| 8 | 2021 | 101 | |
| 9 | 2013 | 93 | |
| 10 | 2011 | 89 | |
| 11 | 2020 | 87 | |
| 12 | 2006 | 87 | |
| 13 | 2010 | 75 | |
| 14 | 2020 | 72 | |
| 15 | 2011 | 64 | |
| 16 | 2014 | 56 | |
| 17 | 2013 | 54 | |
| 18 | 2022 | 54 | |
| 19 | 2016 | 48 | |
| 20 | 2011 | 45 |
About Benjamin Ory
Benjamin Ory is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Rheumatology, having authored 59 papers that have together received 2.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (12 papers), Bone health and treatments (9 papers), Sarcoma Diagnosis and Treatment (9 papers), Cancer-related Molecular Pathways (9 papers), RNA modifications and cancer (8 papers), Ubiquitin and proteasome pathways (6 papers), Protein Degradation and Inhibitors (6 papers) and Bone Metabolism and Diseases (4 papers). The work is most often cited by research in Cancer Research (613 citations), Oncology (952 citations), Molecular Biology (1.3k citations), Pulmonary and Respiratory Medicine (489 citations) and Rheumatology (152 citations). Benjamin Ory has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Dominique Heymann, Françoise Rédiní, François Lamoureux, Marc Baud’huin, Marie‐Françoise Heymann, Leif W. Ellisen, Marta Tellez Gabriel, Lidia Rodriguez Calleja, Céline Charrier and Frédéric Blanchard. Their work appears in journals such as Cancers, Oncotarget, Cancer Research, Cells and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.